Synergistic anticancer activity of a novel oral chemotherapeutic agent containing trifluridine and tipiracil in combination with anti-PD-1 blockade in microsatellite stable-type murine colorectal cancer cells

類似資料

• Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer
  著者:: Suzuki, Norihiko, 等
  出版事項: (2017)
• Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancer
  著者:: Suzuki, Norihiko, 等
  出版事項: (2021)
• Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenografts
  著者:: Suzuki, Norihiko, 等
  出版事項: (2016)
• Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expression
  著者:: Matsuoka, Kazuaki, 等
  出版事項: (2018)
• Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells
  著者:: Matsuoka, Kazuaki, 等
  出版事項: (2018)